Korean J Med.
2018 Dec;93(6):571-574. 10.3904/kjm.2018.93.6.571.
Pneumocystis Pneumonia Developing during Treatment of Recurrent Renal Cell Cancer with Nivolumab
- Affiliations
-
- 1Division of Hematology and Oncology, Department of Internal Medicine, Pohang Semyeong Christianity Hospital, Pohang, Korea.
- 2Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. bhumsuk@snu.ac.kr
- KMID: 2438050
- DOI: http://doi.org/10.3904/kjm.2018.93.6.571
Abstract
- Nivolumab is an immune checkpoint inhibitor approved for the treatment of metastatic cancers. Here, we report the case of a 65-year-old male with recurrent renal cell carcinoma. After six cycles of nivolumab treatment, positron emission tomography/computed tomography (PET/CT) was performed to evaluate the response. PET/CT revealed diffuse ground glass opacities in both lungs. He developed a cough, sputum, chills, and a febrile sense. After bronchoscopic bronchoalveolar lavage, pneumocystis pneumonia was finally diagnosed.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Clinical Study of 15 Cases of Pneumocystis Carinii Pneumonia
- Two Autopsy Cases of Pneumocystis Carinii Pneumonia
- A Case of Pneumocystis Carinii Pneumonia Associated with Cytomegalovirus Lung Infection
- A Case of Pneumocystis carinii Pneumonia with Febrile Neutropenia in Acute Lymphoblastic Leukemia
- A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma
